Grifols (GIFLF) EPS (Diluted) Growth (3y) (2016 - 2025)
Powered by 
Analysis
Grifols (GIFLF) EPS (Diluted) Growth (3y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 19.35% |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -130.36% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 7.01% |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 12.90% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 82.91% |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 18.44% |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 36.39% |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -45.62% |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -86.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -86.81% |
| Dec 31, 2024 | 26.01% |
| Dec 31, 2023 | 26.01% |
| Dec 31, 2022 | -31.81% |
| Dec 31, 2021 | -31.31% |
| Dec 31, 2020 | -30.54% |
| Mar 31, 2020 | 9.99% |
| Dec 31, 2019 | 74.79% |
| Mar 31, 2019 | -14.52% |
| Dec 31, 2018 | 78.70% |
| Jun 30, 2018 | 12.60% |
| Mar 31, 2018 | 22.15% |
| Dec 31, 2017 | 75.29% |
| Jun 30, 2017 | 933.87% |
| Mar 31, 2017 | 14.17% |
| Dec 31, 2016 | 11.91% |